PetMed Express, Inc.
corporate_fare Company Profile
PetMed Express, Inc. (NASDAQ:PETS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 20 items for PETS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for PETS spans 10-Q, 8-K, SCHEDULE 13D/A, DEF 14A.
Recent high-impact activity:
- PetMeds 10-Q: Going-Concern Doubt Disclosed, Material Weaknesses Persist, $37M Sale-Leaseback Pending
- PetMeds Posts 31-Cent Quarterly Loss as Turnaround Pressure Mounts
- PetMeds Names Jeff Willard CEO; Campbell Retires, Mennen Becomes Chair
- PetMed Express Q1 Loss Narrows to $6.1M, But Cash Burn and Going Concern Doubt Persist
- PetMed Q1 Loss Narrows to $6.1M, Sales Stabilize Sequentially
Financial Snapshot
Short Interest & Short Volume
9.12 days to coverFINRA reported short interest of 829,531 shares in PETS as of the October 30, 2026 settlement, a 7.4% decrease from the prior period — about 9.1 days to cover at its recent average daily volume. On November 20, 2026, 56.2% of PETS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.